Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (13 ops.)
Latest filing published 15 Sept 2026 for Neurocrine Biosciences INC. Read the official filing
Filing timeline
BuySaleDarin Lippoldt
Insider track record
Disclosed buys
0
Disclosed sells
13
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Darin Lippoldt: trading record in brief
All filings by Darin Lippoldt on record concern Neurocrine Biosciences Inc, in the capacity of senior executive. Over a trading history stretching from 10 December 2021 to 11 September 2026, the count stands at 38 filings.
The open-market record consists of 13 sales worth €3.6M, with no purchase. No amount is published for 3 filings, which the totals therefore leave out. Outside the open market, there are 2 share grants and 19 option exercises. 2026 to date brings no purchases and 4 sales.
The newest entry dates from 15 September 2026: a share grant, in Neurocrine Biosciences Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Darin Lippoldt
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations38 total
4,483 shares0Common StockSEC:0001504783-26-000019:0
2,419 shares@ US$156.22Common StockSEC:0001504783-26-000019:1
10,000 shares@ US$81.490.0045% mcap8.5% of flowCommon StockSEC:0001504783-26-000017:0
10,000 shares@ US$179.60140.0099% mcap18.7% of flowCommon StockSEC:0001504783-26-000017:1
1,690 sharesCommon StockSEC:0001504783-26-000015:5
200 sharesCommon StockSEC:0001504783-26-000015:0
200 sharesCommon StockSEC:0001504783-26-000015:1
8,110 sharesCommon StockSEC:0001504783-26-000015:2
8,110 sharesCommon StockSEC:0001504783-26-000015:3
1,690 sharesCommon StockSEC:0001504783-26-000015:4
1,792 shares0Common StockSEC:0001504783-26-000011:0
2,373 shares0Common StockSEC:0001504783-26-000007:0
3,349 shares@ US$35.991.7% of flowCommon StockSEC:0001504783-26-000004:0
4,376 shares@ US$43.240.0011% mcap37.3% of flowCommon StockSEC:0001504783-25-000006:0
190 shares0Common StockSEC:0000914475-25-000065:0
1,727 shares0Common StockSEC:0000914475-25-000050:0
2,373 shares0Common StockSEC:0000914475-25-000026:0
2,996 shares@ US$79.023.5% of flowCommon StockSEC:0000914475-24-000185:0
7,004 shares@ US$79.028.2% of flowCommon StockSEC:0000914475-24-000168:0
1,098 shares@ US$132.99492.2% of flowCommon StockSEC:0000914475-24-000074:0
1,041 shares@ US$142.16632.2% of flowCommon StockSEC:0000914475-24-000048:0
1,250 shares@ US$140.64782.6% of flowCommon StockSEC:0000914475-24-000029:0
10,000 shares@ US$79.0211.7% of flowCommon StockSEC:0000914475-24-000011:0
20,830 shares@ US$43.2413.4% of flowCommon StockSEC:0000914475-23-000082:0
10,919 shares@ US$112.273218.0% of flowCommon StockSEC:0001209191-23-056907:0
25 of 38 declarations
